Literature DB >> 21533906

CD45-CD14 +CD34 + murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation potential in long-term in vitro culture.

Krzysztof Szade1, Ewa Zuba-Surma, Andrzej J Rutkowski, Alicja Jozkowicz, Jozef Dulak.   

Abstract

Bone marrow-derived cells have been postulated as a source of multipotent mesenchymal stem cells (MSC). However, the whole fraction of MSC remains heterogeneous and the expansion of primitive subset of these cells is still not well established. Here, we optimized the protocol for propagating the low-adherent subfraction of MSC which results in long-term expansion of population characterized by CD45(-)CD14(+)CD34(+) phenotype along with expression of common MSC markers. We established that the expanded MSC are capable of differentiating into endothelial cells highly expressing angiogenic markers and exhibiting functional properties of endothelium. Moreover, we found these cells to be multipotent and capable of giving rise into cells from neuronal lineages. Interestingly, the expanded MSC form characteristic cellular spheres in vitro indicating primitive features of these cells. In sum, we isolated the novel multipotent subpopulation of CD45(-)CD14(+) CD34(+) bone marrow-derived cells that could be maintained in long-term culture without losing this potential.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533906      PMCID: PMC3887617          DOI: 10.1007/s10059-011-2176-y

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  44 in total

Review 1.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

2.  Endothelial progenitor cell and mesenchymal stem cell isolation, characterization, viral transduction.

Authors:  Keith R Brunt; Sean R R Hall; Christopher A Ward; Luis G Melo
Journal:  Methods Mol Med       Date:  2007

3.  Purification and growth of endothelial progenitor cells from murine bone marrow mononuclear cells.

Authors:  Qi Ru Wang; Bao He Wang; Yan Hong Huang; Guo Dai; Wei Ming Li; Qi Yan
Journal:  J Cell Biochem       Date:  2008-01-01       Impact factor: 4.429

Review 4.  Critical review of clinical trials of bone marrow stem cells in liver disease.

Authors:  Diarmaid Dominic Houlihan; Philip Noel Newsome
Journal:  Gastroenterology       Date:  2008-05-15       Impact factor: 22.682

5.  Is it possible to obtain "true endothelial progenitor cells" by in vitro culture of bone marrow mononuclear cells?

Authors:  Shi Ju Zhang; Hao Zhang; Mai Hou; Zhe Zheng; Jianye Zhou; Wenjun Su; Yingjie Wei; Shengshou Hu
Journal:  Stem Cells Dev       Date:  2007-08       Impact factor: 3.272

6.  CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization.

Authors:  Ian Copland; Kapil Sharma; Laurence Lejeune; Nicoletta Eliopoulos; Duncan Stewart; Peter Liu; Kevin Lachapelle; Jacques Galipeau
Journal:  Exp Hematol       Date:  2007-11-26       Impact factor: 3.084

7.  Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction.

Authors:  Buddhadeb Dawn; Sumit Tiwari; Magdalena J Kucia; Ewa K Zuba-Surma; Yiru Guo; Santosh K Sanganalmath; Ahmed Abdel-Latif; Greg Hunt; Robert J Vincent; Hisham Taher; Nathan J Reed; Mariusz Z Ratajczak; Roberto Bolli
Journal:  Stem Cells       Date:  2008-04-17       Impact factor: 6.277

Review 8.  Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.

Authors:  Enca Martin-Rendon; Susan J Brunskill; Chris J Hyde; Simon J Stanworth; Anthony Mathur; Suzanne M Watt
Journal:  Eur Heart J       Date:  2008-06-03       Impact factor: 29.983

Review 9.  Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.

Authors:  Dimitrios Karussis; Ibrahim Kassis; Basan Gowda S Kurkalli; Shimon Slavin
Journal:  J Neurol Sci       Date:  2007-07-03       Impact factor: 3.181

10.  Comparative study of mesenchymal stem cells from C57BL/10 and mdx mice.

Authors:  Yong Li; Cheng Zhang; Fu Xiong; Mei-juan Yu; Fu-Lin Peng; Yan-chang Shang; Cui-ping Zhao; Yong-feng Xu; Zheng-shan Liu; Chang Zhou; Jin-lang Wu
Journal:  BMC Cell Biol       Date:  2008-05-19       Impact factor: 4.241

View more
  12 in total

1.  Novel in vitro culture condition improves the stemness of human dermal stem/progenitor cells.

Authors:  Joong Hyun Shim; Tae Ryong Lee; Dong Wook Shin
Journal:  Mol Cells       Date:  2013-11-14       Impact factor: 5.034

2.  CXCL12/SDF-1-Dependent Retinal Migration of Endogenous Bone Marrow-Derived Stem Cells Improves Visual Function after Pharmacologically Induced Retinal Degeneration.

Authors:  Volker Enzmann; Stéphanie Lecaudé; Anna Kruschinski; Axel Vater
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

3.  Transcriptomes of human mesenchymal cells isolated from the right ventricle and epicardial fat differ strikingly both directly after isolation and long-term culture.

Authors:  Jacek Stępniewski; Urszula Florczyk-Soluch; Krzysztof Szade; Karolina Bukowska-Strakova; Justyna Czapla; Sybilla Matuszczak; Magdalena Jarosz-Biej; Agnieszka Langrzyk; Mateusz Tomczyk; Izabela Rumieńczyk; Maria Kulecka; Michał Mikuła; Jerzy Ostrowski; Agnieszka Jaźwa-Kusior; Marian Zembala; Alicja Józkowicz; Michał Oskar Zembala; Józef Dulak
Journal:  ESC Heart Fail       Date:  2019-01-09

4.  MicroRNA-30a regulates chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells through targeting Sox9.

Authors:  Hongqi Zhang; Yunjia Wang; Guanteng Yang; Honggui Yu; Zhenhai Zhou; Mingxing Tang
Journal:  Exp Ther Med       Date:  2019-10-30       Impact factor: 2.447

5.  Negative Regulation of the Differentiation of Flk2- CD34- LSK Hematopoietic Stem Cells by EKLF/KLF1.

Authors:  Chun-Hao Hung; Keh-Yang Wang; Yae-Huei Liou; Jing-Ping Wang; Anna Yu-Szu Huang; Tung-Liang Lee; Si-Tse Jiang; Nah-Shih Liao; Yu-Chiau Shyu; Che-Kun James Shen
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

6.  Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway.

Authors:  Wen-hua Liu; Jing-jin Liu; Jian Wu; Lu-lu Zhang; Fang Liu; Li Yin; Mao-mao Zhang; Bo Yu
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

Review 7.  The uncertain role of unmodified mesenchymal stem cells in tumor progression: what master switch?

Authors:  Liyang Zhang; Juanjuan Xiang; Guiyuan Li
Journal:  Stem Cell Res Ther       Date:  2013-03-18       Impact factor: 6.832

8.  Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell.

Authors:  Moonhwan Choi; Taehyun Ban; Taiyoun Rhim
Journal:  Mol Cells       Date:  2014-02-19       Impact factor: 5.034

9.  Enhanced healing of rat calvarial defects with MSCs loaded on BMP-2 releasing chitosan/alginate/hydroxyapatite scaffolds.

Authors:  Xiaoning He; Yang Liu; Xue Yuan; Li Lu
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

10.  Osteogenic differentiation potential of porcine bone marrow mesenchymal stem cell subpopulations selected in different basal media.

Authors:  Sangeetha Kannan; Jyotirmoy Ghosh; Sujoy K Dhara
Journal:  Biol Open       Date:  2020-10-19       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.